is a symbol of the 80s
Vaccines.
EU: Astrazeneca respects commitments, we ask for a shipping plan
Coronavirus, Ema: Astrazeneca has requested authorization for the vaccine
AstraZeneca: first deliveries to the EU lower than expected
Vaccini, Arcuri: 15 million doses by March, first AstraZeneca delivery on February 15
Share
January 26, 2021 The pharmaceutical giant AstraZeneca has denied the reports reported by some German media, such as 'Bild' and 'Handelsblatt', on the reduced efficacy of its vaccine, developed with the University of Oxford, on over 65.
"The reports according to that the effectiveness of the AstraZeneca / Oxford vaccine is 8% in adults over the age of 65 are completely wrong, "an AstraZeneca spokesperson told Deutsche Welle.
The company said a major UK vaccination committee, the Joint Committee on Vaccination and Immusination (JCVI), and the UK Medicines Agency (MHRA) have supported the use of its vaccine in that particular age group.
"In November, we published data in 'The Lancet' showing that the elderly showed strong immune responses to the vaccine, with 100% of the elderly generating specific antibodies after the second dose," added the AstraZeneca spokesperson.
The company's response came after the German newspapers Handelsblatt and Bild, citing anonymous government sources, reported that the vaccine had poor efficacy on the over 65s. In particular, Bild reported an effectiveness at "less than 10%. "and Handelsblatt at 8%.